Divergent resistance mechanisms to immunotherapy explains response in different skin cancers.
E. Dollinger, D. Bergman, P. Zhou, S. Atwood, Q. Nie
This study identifies divergent immune resistance mechanisms in melanoma and basal cell carcinoma that explain differential responses to checkpoint immunotherapy.
bioRxiv · Sep 15, 2020Cancer Biology